Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: Diagnosis, staging, and surveillance of prostate cancer
Kundra V, et al (2007) Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer. Am J Roentgenol 189: 830-844.
Magnetic resonance imaging anatomy of the prostate and periprostatic area: A guide for radiotherapists
Villeirs GM, et al (2005) Magnetic resonance imaging anatomy of the prostate and periprostatic area: a guide for radiotherapists. Radiother Oncol 76: 99-106.
Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning
Villeirs GM, et al (2007) Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning. Eur J Radiol 63: 361-368.
The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer
Debois M, et al (1999) The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 45: 857-865.
CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer
Sannazzari GL, et al (2002) CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer. Br J Radiol 75: 603-607.
Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate
Steenballers RJHM, et al (2003) Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 57: 1269-1279.
Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for the 3D conformal radiation therapy
Kagawa K, et al (1997) Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for the 3D conformal radiation therapy. Int J Radiat Oncol Biol Phys 38: 319-325.
Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer
Villeirs GM, et al (2005) Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer. Strahlenther Onkol 18: 424-430.
Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy
Roach M, et al (1996) Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 35: 1011-1018.
Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: Dose-volume effect
Zapatero A, et al (2004) Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect. Int J Radiat Oncol Biol Phys 59: 1343-1351.
Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: Analysis of a large group of patients pooled from three institutions
Fiorino C, et al (2002) Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. Radiother Oncol 64: 1-12.
Rectal dose-volume constrains in high-dose radiotherapy of localized prostate cancer
Fiorino C, et al (2003) Rectal dose-volume constrains in high-dose radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 57: 953-962.
Finding dose-volume constrains to reduce late rectal toxicity following 3D-confromal radiotherapy (3D-CRT) of prostate cancer
Greco C, et al (2003) Finding dose-volume constrains to reduce late rectal toxicity following 3D-confromal radiotherapy (3D-CRT) of prostate cancer. Radiother Oncol 69: 215-222.